The Treatment of HR+ Early-Stage Breast Cancer

Presented by

Dr. Ivana Sestak

About this talk

Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature. From current to emerging treatment options, the speakers will discuss different biomarker strategies that support shared decision-making for the management of hormone-receptor positive (HR+) patients.

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (15)
Subscribers (3243)
Our webinars provide engaging and educational content for healthcare professionals, featuring a range of stimulating presentations, thought-provoking interviews with industry experts, and news and updates from the field.